Vascular Involvement of the Liver in Turner's Syndrome

Hepatology

Volumn 39, Issue 1, 2004, Pages 239-247

  Roulot, Dominique ^a,f   Degott, Claude ^b   Chazouillères, Olivier ^c   Oberti, Frédéric ^d   Calès, Paul ^d   Carbonell, Nicolas ^c   Benferhat, Said ^b   Bresson Hadni, Solange ^e   Valla, Dominique ^b  

^a HÔPITAL JEAN VERDIER   (France)

^b BEAUJON HOSPITAL   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY HOSPITAL OF BESANÇON   (France)

^f UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AORTA ANOMALY; ARTICLE; ASCITES; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ESTROGEN THERAPY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER HEMORRHAGE; LIVER HYPERPLASIA; LIVER TOXICITY; LIVER TRANSPLANTATION; NODULAR HYPERPLASIA; NONALCOHOLIC FATTY LIVER; PORTAL HYPERTENSION; PRIORITY JOURNAL; RECURRENT DISEASE; SCLEROSING CHOLANGITIS; TURNER SYNDROME; VASCULAR DISEASE; AORTA; BIOPSY; BLOOD; COHORT ANALYSIS; CONGENITAL MALFORMATION; ECHOGRAPHY; ESOPHAGUS VARICES; FEMALE; GALLSTONE; LIVER CIRCULATION; MIDDLE AGED; PATHOLOGY; PORTAL VEIN;

BILIRUBIN;

ADULT; AORTA; BILIRUBIN; BIOPSY; COHORT STUDIES; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; GALLSTONES; HUMANS; LIVER CIRCULATION; LIVER DISEASES; MIDDLE AGED; PORTAL VEIN; TURNER SYNDROME;

EID: 1442281954     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20026     Document Type: Article

References (42)

1. Saenger P. Turner's syndrome. N Engl J Med 1996;335:1749-1754.
2. Sylven L, Hagenfeldt K, Brondum-Nielsen K, von Schoultz B. Middle-aged women with Turner's syndrome. Medical status, hormonal treatment and social life. Acta Endocrinol 1991;125:359-365.
3. Larizza D, Locatelli M, Vitali L, Vigano C, Calcaterra V, Tinelli C, Sommaruga MG, et al. Serum liver enzymes in Turner syndrome. Eur J Pediatr 2000;159:143-148.
4. Salerno M, Di Maio S, Gasparini N, Rizzo M, Ferri P, Vajro P. Liver abnormalities in Turner syndrome. Eur J Pediatr 1999;158:618-623.
5. Elsheikh M, Hodgson HJ, Wass JA, Conway GS. Hormone replacement therapy may improve hepatic function in women with Turner's syndrome. Clin Endocrinol 2001;55:227-231.
6. Floreani A, Molaro M, Baragiotta A, Naccarato R. Chronic cholestasis associated with Turner's syndrome. Digestion 1999;60:587-589.
7. Friedman E, Theodor E, Austein A, Sack J. Cirrhosis in Turner's syndrome. Harefuah 1980;98:210-211.
8. Krivosheev AB. Development of liver cirrhosis in a female patient with Shereshevskii-Turner syndrome. Klin Med 1990;68:95-96.
9. Idilman R, De Maria N, Colantoni A, Kugelmas M, Van Thiel DH. Cirrhosis in Turner's syndrome: case report and literature review. Eur J Gastroenterol Hepatol 2000;12:707-709.
10. de Ledinghen V, Levillain P, Besson I, Palazzo L, Fabre M, Silvain C, Morichau-Beauchant M. Nodular regenerative hyperplasia of the liver and Turner syndrome. Gastroenterol Clin Biol 1994;18:898-899.
11. Thevenot T, Dhote R, Tulliez M, Baverel F, Permal S, Rabineau D, Christoforov B. Turner syndrome and nodular regenerative hyperplasia of the liver. Ann Med Interne 1998;149:295-296.
12. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. HEPATOLOGY 1994;20:15-20.
13. Wanless IR. Vascular disorders. In: MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC, eds. Pathology of the Liver. London: Churchill Livingstone, 2002:539-565.
14. Albareda MM, Gallego A, Enriquez J, Rodriguez JL, Webb SM. Biochemical liver abnormalities in Turner's syndrome. Eur J Gastroenterol Hepatol 1999;11:1037-1039.
15. Gardner LI. Intrahepatic bile stasis in 45,X Turner's syndrome [letter]. N Engl J Med 1974;290:406.
16. Molland EA, Purcell M. Biliary atresia and the Dandy-Walker anomaly in a neonate with 45,X Turner's syndrome. J Pathol 1975;115:227-230.
17. Andrade RJ, Alcantara R, Fraile JM, Lazo MD, Llamas A, Carmona C, Franquelo E. Chronic asymptomatic intrahepatic cholestasis associated with Turner's syndrome. Gastroenterol Hepatol 1995;18:375-378.
18. Szekely AM, Franco D, Dupuy JM, Job JC. Liver anomalies with portal hypertension associated with Turner's syndrome. Arch Anat Cytol Pathol 1976;24:311-316.
19. Garavelli L, Donadio A, Banchini G, Fornaciari G, Plancher AC, Franchi F, Gardini G. Liver abnormalities and portal hypertension in Ullrich-Turner syndrome. Am J Med Genet 1998;80:180-182.
20. Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol 1998;51:147-158.
21. Rougier P, Degott C, Rueff P, Benhamou JP. Nodular regenerative hyperplasia of the liver. Report of 6 cases and review of the literature. Gastroenterology 1978;75:169-172.
22. Wanless IR, Godwin TA, Allen F, Feder A. Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative venopathy. A morphometric study of 9 cases with an hypothesis on the pathogenesis. Medicine 1980;59:367-379.
23. Stromeyer FW, Ishak KG. Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathological study of 30 cases. Human Pathology 1981;12:60-70.
24. Wanless IR, Solt LC, Kortan P, Dec JHN, Gariner GW, Prokipchuk J. Nodular regenerative hyperplasia of the liver associated with macroglobulinemia. Am J Med 1981;70:1203-1207.
25. Voinchet O, Degott C, Scoazec JY, Feldmann G, Benhamou JP. Peliosis hepatis, nodular regenerative hyperplasia of the liver and light chains deposition in a patient with Waldenstrom's macroglobulinemia. Gastroenterology 1988;95:482-486.
26. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. HEPATOLOGY 1990;11:787-797.
27. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. HEPATOLOGY 1985;5:1194-1200.
28. Wanless IR, Lentz JS, Roberts EA. Partial nodular transformation of liver in an adult with persistent ductus venosus. Review with hypothesis on pathogenesis. Arch Pathol Lab Med 1985;109:427-432.
29. Motoori S, Shinozaki M, Goto N, Kondo F. Congenital absence of the portal vein associated with nodular hyperplasia in the liver [case report]. J Gastroenterol Hepatol 1997;12:639-643.
30. Kinjo T, Aoki H, Sunagawa H, Kinjo S, Muto Y. Congenital absence of the portal vein associated with focal nodular hyperplasia of the liver and congenital choledochal cyst: a case report. J Pediatr Surg 2001;36:622-625.
31. Mazzanti L, Prandstraller D, Tassinari D, Rubino I, Santucci S, Picchio FM, Forabosco A, et al. Heart disease in Turner's syndrome. Helv Paediat Acta 1988;43:25-31.
32. Mazzanti L, Cacciari E. Congenital heart disease in patients with Turner's syndrome. Italian study group for Turner syndrome. J Pediatr 1998;133:688-692.
33. Prandstraller D, Mazzanti L, Picchio F, Magnani C, Bergamaschi R, Perri A, Tsingos E, et al. Turner's syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-up of 136 nonpreselected patients. Ped Cardiol 1999;20:108-112.
34. Weinrieb IJ, Fineman RM, Spiro HM. Turner syndrome and inflammatory bowel disease. N Engl J Med 1976;294:1221-1222.
35. Price WH. A high incidence of chronic inflammatory bowel disease in patients with Turner's syndrome. J Med Genet 1979;16:263-266.
36. Goritsas CP, Repanti M, Papadaki E, Lazarou N, Andonopoulos AP. Intrahepatic bile duct injury and nodular regenerative hyperplasia of the liver in a patient with polyarteritis nodosa. J Hepatol 1997;26:727-730.
37. Batts KP. Ischemic cholangitis. Mayo Clin Proc 1998;73:380-385.
38. Fukuzumi S, Moriya Y, Makuuchi M, Terui S. Serious chemical sclerosing cholangitis associated with hepatic arterial 5FU and MMC chemotherapy. Eur J Surg Oncol 1990;16:251-255.
39. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vincenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr Gastroenterol Nutr 1994;125:239-241.
40. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, et al. Liver fibrosis in overweight patients. Gastroenterology 2000;118:1117-1123.
41. Hannaford PC, Kay CR, Vessey MP, Painter R, Mant J. Combined oral contraceptives and liver disease. Contraception 1997;55:145-151.
42. Lindberg MC. Hepatobiliary complications of oral contraceptives. J Gen Intern Med 1992;7:199-209.